BioMedNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Launches Upgraded MedOfficeDirect Platform on Shopify

HealthLynked (OTCQB: HLYK), a leading provider of healthcare technology and patient engagement solutions, announced the launch of its new MedOfficeDirect e-commerce platform, now live at DiscountOnlineMedicalSupplies.com and built on Shopify. The upgraded platform delivers faster performance, enhanced security, and a modern checkout experience while offering an average 20% price reduction across its catalog of brand-name medical supplies. HealthLynked plans to expand the curated inventory and, upon completing its marketing and backend transition, migrate the platform back to MedOfficeDirect.com. CEO Dr. Michael Dent said the launch represents a major step forward in accessibility and scalability, enabling patients and healthcare providers to purchase essential products through a faster, more reliable system.

To view the full press release, visit https://ibn.fm/deMzj

About HealthLynked Corp.

HealthLynked Corp. is transforming healthcare by connecting patients and providers through a secure, cloud-based network. The company’s platform consolidates medical records, offers AI-driven care guidance, enables appointment booking and telemedicine, and supports a growing ecosystem of healthcare products and services.

NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYLK

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — Earth Science Tech, Inc. (OTC: ETST) Launches MyOnlineConsultation Platform Through MOCTeledoc 

Earth Science Tech (OTC: ETST) announced the official launch of MyOnlineConsultation.com through MOCTeledoc LLC, a fully integrated doctor…

19 hours ago

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights Operational Progress

NRx Pharmaceuticals (NASDAQ: NRXP) announced the filing of its Form 10-K for the year ended Dec.…

19 hours ago

BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) To Present Deciparticle Platform And Pipeline At BIO-Europe Spring 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced that its subsidiary Sapu Nano will present its Deciparticle (TM)…

21 hours ago

BioMedNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Advances Anti-Drone Capabilities Through AFD Deployment Of Anduril Lattice Platform

Gaxos.ai (NASDAQ: GXAI) announced that its portfolio company, America First Defense (AFD), has begun deployment…

21 hours ago

BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Advances Orphan Drug Strategy With HyBryte In Rare Skin Cancer

Soligenix (NASDAQ: SNGX) is advancing a differentiated approach to orphan drug development, emphasizing a de-risked model focused…

2 days ago

BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting 

Soligenix (NASDAQ: SNGX) announced that new supportive trial data for HyBryte(TM) in the treatment of cutaneous T-cell lymphoma…

2 days ago